Updated: April 16, 2026
How to Help Your Patients Save Money on Relador: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- The Core Strategy: Prescribe Generic by Default
- Prescription Discount Cards: Direct Patient Savings Tools
- Insurance Coverage Optimization
- HSA and FSA: Pre-Tax Dollar Savings for Insured Patients
- Manufacturer and Patient Assistance Programs
- In-Office Supply: Reducing the Burden for Procedure Patients
- When Patients Can't Find Relador: Using medfinder
A provider's guide to reducing out-of-pocket costs for patients prescribed Relador (lidocaine-prilocaine cream) in 2026 — from generic switching to assistance programs.
When a patient is prescribed Relador (lidocaine-prilocaine 2.5%/2.5% cream) before a procedure, cost can become a significant barrier to care — brand Relador Pak has a retail price of approximately $1,528.79 per kit. Patients who hit this cost barrier may skip the topical anesthetic altogether, impacting their procedural experience and your clinical workflow. This guide gives providers actionable tools to help patients obtain Relador or its equivalent at dramatically lower cost.
The Core Strategy: Prescribe Generic by Default
The highest-impact change you can make is to prescribe generic lidocaine-prilocaine 2.5%/2.5% cream as your default — not Relador Pak by brand name. This single practice change can reduce your patient's out-of-pocket cost from $1,528 to as little as $19–$34 with a discount card.
Best prescribing practice:
Write: "Lidocaine 2.5%/prilocaine 2.5% topical cream — DAW 0 (generic substitution permitted)"
Specify the quantity needed (typically 5–30 g depending on the procedure area)
Include application instructions in the prescription or procedure prep notes, as patients will need to know how much to apply and for how long
Note that patients can use a standard Tegaderm or plastic food wrap as the occlusive dressing if using generic cream without the kit
Prescription Discount Cards: Direct Patient Savings Tools
Prescription discount cards are one of the most powerful savings tools available to uninsured or underinsured patients — and they require no application, no income verification, and no waiting period. Consider printing or posting these in your practice:
GoodRx (goodrx.com): Shows prices at pharmacies near the patient's ZIP code. Generic lidocaine-prilocaine is typically $15–$30 with GoodRx at major chains. Patients can show the coupon on their phone at the pharmacy.
SingleCare (singlecare.com): Lists generic lidocaine-prilocaine as low as $19.62 per kit at participating pharmacies. Free card with no enrollment.
Rx.com: Compares prices across 60,000+ US pharmacies and can reduce costs by up to 90% on generics.
Clinical workflow tip: Add a GoodRx or SingleCare QR code to your procedure prep handout. Patients can scan it directly to find the lowest-cost option near them before picking up their prescription.
Insurance Coverage Optimization
For patients with insurance, help them navigate coverage effectively:
Generic lidocaine-prilocaine is Tier 1–2 on most commercial formularies and Medicare Part D — a $0–$50 copay in most plans
Brand Relador Pak may require prior authorization or not be covered at all — prescribing generically avoids this barrier entirely
Some plans may classify lidocaine-prilocaine as a procedure supply and require a different billing pathway — check with your billing team if patients are reporting coverage denials
For Medicare patients: Part D covers prescription topical anesthetics; confirm the specific plan formulary using Medicare's drug plan finder
HSA and FSA: Pre-Tax Dollar Savings for Insured Patients
Remind patients that prescription medications, including Relador and generic lidocaine-prilocaine cream, are eligible for payment through Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). Most patients are unaware they can use their HSA/FSA card at a standard pharmacy. For patients in the 22–32% tax bracket, using pre-tax dollars reduces effective medication cost by that percentage.
Manufacturer and Patient Assistance Programs
As of 2026, Accelis Pharma (maker of Relador) does not appear to operate a publicly listed patient assistance program (PAP) or manufacturer copay card. For patients with financial hardship who cannot afford the generic with a discount card, the following resources may help:
NeedyMeds.org: A database of patient assistance programs, disease-specific funds, and community pharmacy assistance
Partnership for Prescription Assistance (PPA): Connects patients with manufacturer assistance programs for brand-name drugs
Hospital social workers and financial counselors: Can identify local resources for uninsured patients facing medication cost barriers
In-Office Supply: Reducing the Burden for Procedure Patients
For practices performing procedures that regularly require topical anesthesia, consider supplying Relador or generic lidocaine-prilocaine cream as a practice-supplied procedural item rather than requiring a separate patient prescription fill:
Purchase generic lidocaine-prilocaine in bulk through medical distributors (Cardinal Health, McKesson, Cencora) at significantly lower per-unit cost than retail
Apply the cream in-office 60 minutes before the procedure, eliminating the need for the patient to source and bring it
Bill as a procedural supply or include in the procedure fee, depending on your payer contracts
This approach is especially useful during shortage periods when patients struggle to fill prescriptions at retail pharmacies
When Patients Can't Find Relador: Using medfinder
Cost is only part of the challenge — availability is the other. Patients who cannot find Relador or generic lidocaine-prilocaine at their pharmacy can use medfinder for providers, a paid service that contacts pharmacies on the patient's behalf to find which ones currently have the medication in stock. Directing patients to medfinder reduces missed procedures and saves your staff from taking patient callback calls about unavailable medications. For more guidance see our provider guide to helping patients find Relador.
Frequently Asked Questions
The most effective step is to prescribe generic lidocaine-prilocaine 2.5%/2.5% cream (DAW 0) rather than brand Relador Pak. Generic prices drop to $19–$34 with GoodRx or SingleCare discount cards. Additionally, remind patients to use HSA/FSA funds for prescription topical anesthetics.
Accelis Pharma does not publicly list a patient assistance program or manufacturer copay card for Relador as of 2026. For patients with financial hardship, direct them to NeedyMeds.org, the Partnership for Prescription Assistance, or your hospital's social work/financial counseling services.
Yes. Prescribing generic lidocaine-prilocaine 2.5%/2.5% cream (DAW 0) rather than brand Relador Pak typically avoids prior authorization requirements, since generics are routinely placed on Tier 1–2 formularies. Brand Relador Pak is more likely to require PA or step therapy compliance.
Yes. Practices that perform procedures requiring topical anesthesia can purchase generic lidocaine-prilocaine cream in bulk through medical distributors (Cardinal Health, McKesson, Cencora) and supply it as a procedural item. This eliminates the patient-side burden of finding and filling a prescription, particularly valuable during shortage periods.
Direct patients to medfinder (medfinder.com), a paid service that contacts pharmacies on their behalf to identify which ones currently have the medication in stock. Also recommend they ask for the generic equivalent (lidocaine-prilocaine cream) and try multiple pharmacy types — including independents and mail-order. Consider maintaining in-office supply to avoid procedure delays.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Relador also looked for:
More about Relador
35,181 have already found their meds with Medfinder.
Start your search today.





